Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page
- Check6 days agoChange DetectedAdded a new site revision tag Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a deployment update to the interface, with no changes to the study details or results displayed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical trial details.SummaryDifference0.1%

- Check34 days agoChange DetectedPage revision updated to v3.5.2, replacing v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.3 replacing v3.4.2. This appears to be a system/UI update with no changes to the study details presented on the page.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded Revision: v3.4.2 and removal of the general government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.